Home › Linfoma follicolare › Ohio › Columbus
Studi clinici su Linfoma follicolare a Columbus, OH
13 studi su Linfoma follicolare cercano partecipanti presso sedi a Columbus e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
In reclutamentoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Epco, Zanu, Ritux for R/R FL or MZL
In reclutamentoFase 2
- The Ohio State University Wexner Medical Center, Columbus
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
In reclutamentoFase 1
- The Ohio State University (OSU), Columbus
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
In reclutamentoFase 3
- Research Site, Columbus
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
In reclutamentoFase 2
- Research Site, Columbus
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
In reclutamentoStudio osservazionale
- OhioHealth Research Institute, Columbus
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
In reclutamentoFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
In reclutamentoFase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Epcoritamab and Rituximab for First-line Follicular Lymphoma
In reclutamentoFase 2
- The Ohio State University Wexner Medical Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
In reclutamentoFase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
In reclutamentoFase 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
In reclutamentoFase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Studi su Linfoma follicolare in altre città
- New York City, NY24 studi
- Milwaukee, WI19 studi
- Nashville, TN18 studi
- Houston, TX18 studi
- Boston, MA17 studi
- Baldwin Park, CA16 studi
- Seattle, WA15 studi
- Durham, NC15 studi
- Salt Lake City, UT13 studi
- San Antonio, TX12 studi
- Chicago, IL12 studi
- Philadelphia, PA12 studi
Altri studi a Columbus
- Cancro del polmone non a piccole cellule56 studi
- Cancro al seno39 studi
- Cancro ovarico39 studi
- Cancro (tutti i tipi)38 studi
- Cancro ai polmoni37 studi
- Leucemia mieloide acuta35 studi
- Leucemia linfatica cronica28 studi
- Cancro metastatico27 studi
- Cancro dell'endometrio25 studi
- Cancro colorettale24 studi
- Cancro alla prostata24 studi
- Mieloma multiplo24 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.